Intestinal Neurofibromatosis Is a Subtype of Familial GIST and Results From a Dominant Activating Mutation in PDGFRA-Reference-Cited by-同舟云学术

Intestinal Neurofibromatosis Is a Subtype of Familial GIST and Results From a Dominant Activating Mutation in PDGFRA

Published:2006-12 Issue:6 Volume:131 Page:1907-1912
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

de Raedt Thomas,Cools Jan,Debiec–Rychter Maria,Brems Hilde,Mentens Nicole,Sciot Raf,Himpens Jacques,de Wever Ivo,Schöffski Patrick,Marynen Peter,Legius Eric

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference18 articles.

1. Hereditary intestinal neurofibromatosis. I;Heimann;Neurofibromatosis,1988

2. Familial enteric neurofibromatosis;Lipton;Med Times,1966

3. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics;Andersson;Am J Surg Pathol,2005

4. Diagnosis of gastrointestinal stromal tumors: a consensus approach;Fletcher;Hum Pathol,2002

5. Biology of gastrointestinal stromal tumors;Corless;J Clin Oncol,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rare PDGFRA Exon 15 Germline Mutation Identified in a Patient With Phenotypic Manifestations Concerning for GIST-Plus Syndrome: A Case Report and Review of Literature;International Journal of Surgical Pathology;2023-02-19

2. Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships;European Journal of Medical Genetics;2022-11

3. Molecular Pathogenesis of Gastrointestinal Stromal Tumor: A Paradigm for Personalized Medicine;Annual Review of Pathology: Mechanisms of Disease;2022-01-24

4. Hereditary inflammatory fibroid polyps caused by germline pathogenic variants in PDGFRA: Refining PDGFRA-mutation syndrome;Cancer Genetics;2021-08

5. A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity;Journal of Personalized Medicine;2020-11-17